Canada Vigilance Program - Collecting and Assessing Adverse Reaction Reports (French, HTML)

View metadata and access the original French HTML file: Canada Vigilance Program - Collecting and Assessing Adverse Reaction Reports.

Format

HTML

Access

file-only

Publisher-reported update

2024-03-30

The Canada Vigilance Program collects and assesses reports of suspected adverse reactions to marketed health products in Canada, including prescription and non-prescription medications; natural health products; biologically derived products such as vaccines and fractionated blood products; cells, tissues and organs; radiopharmaceuticals; and disinfectants and sanitizers with disinfectant claims.

Access original file